2 employees
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments.
2020
$15M
from 1 investors over 1 rounds
Lengo Therapeutics raised $15M on May 12, 2020
Investors: Frazier Healthcare Partners